Description
We are recruiting subjects ages 18-55 for a clinical trial testing an investigational treatment
for diabetes. The study aims to determine the maximum tolerated dose of harmine and
characterize its effects. Participation involves a thorough psychiatric and medical screening
as well as dosing of the investigational drug harmine. You will be compensated for your
time.
For more information, please call the Mount Sinai Depression and Anxiety Center at 212-
241-6133 or email Leah Israel at [email protected],
PI: James Murrough, MD, PhD; STUDY-20-01329; GCO #20-1458
Discussion
By posting you agree to the Terms and Privacy Policy.